FOLH1 and prostate cancer: For instance, literature has reported that PDA-PEG-ACUPA nanomicelles achieve active targeting through the PSMA ligand ACUPA, significantly enhancing drug internalization in prostate cancer cells (Rosales-Barrios et al., 2025).